NeuMoDx Molecular has developed a superior molecular diagnostic (MDx) system for hospital central lab and clinical reference laboratory customers. The Company’s patented, ‘sample-to-result’ platforms offer market-leading ease of use, true random access, continuous loading and rapid turnaround time while achieving a low cost per test. The initial test menu is focused on women’s health assays (CT/GC, GBS and Trichomonas) and quantitative tests for blood born viruses (HCV, HBV and HIV).
Included in the Export Interest Directory? No
Business Needs: Joint Ventures, Licensing Agreements, Service (Maintenance, Training, Logistics, etc.)